Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study
- 10 November 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 32 (4) , 743-752
Abstract
Primary aldosteronism (PA) is associated with increased urinary calcium excretion and osteoporosis prevalence. We studied the long-term effect of hyperaldosterone on fracture risk and possible risk mitigation via treatments, by comparing PA patients and their essential hypertension (EH) counterparts extracted by propensity score match. We used a longitudinal population database from the Taiwan National Health Insurance, and used a validated algorithm to identify PA patients diagnosed in 1997–2010. Our sample included 2533 PA patients, including 921 patients with aldosterone-producing adenoma (APA). Our methods for assessing excessive fracture risk included multivariable Cox regression and the competing risk regression. The incidence rate of fracture at any site was 14.4 per 1000 person-years for PA, and 11.2 per 1000 person-years for APA. In contrast, the incidence rate of fracture at any site was 8.3 per 1000 person-years in EH controls for PA, and 6.5 per 1000 person-years in EH controls for APA. Mineralocorticoid receptor antagonist (MRA) treatment might be associated with higher risk of osteoporotic fracture in the whole female PA cohort (subdistribution hazard ratio [SHR] = 2.12, p = 0.008) as well as female APA patients (SHR = 1.15, p = 0.049). As to fracture at any site, MRA treatment was also associated with higher risk; the SHR was 1.88 (p < 0.001) in the whole female PA cohort, and 2.17 (p = 0.019) in female APA patients. PA is tightly associated with higher risk of bone fracture, even in the case where the competing risk of death was controlled. Particularly, female PA patients treated with MRA were confronted with significantly higher risk in bone fracture than their EH controls. © 2016 American Society for Bone and Mineral Research.Keywords
Funding Information
- National Taiwan University Hospital
- Taiwan's National Health Research Institutes
- Ministry of Science and Technology, Taiwan
- National Science Council, Taiwan
This publication has 24 references indexed in Scilit:
- Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in TaiwanJournal of Clinical Epidemiology, 2014
- Incidence and Risk of Venous Thromboembolism Among Taiwan Osteoporotic Fracture Population under Osteoporosis Pharmacological TreatmentsThe Journal of Clinical Endocrinology & Metabolism, 2014
- The Impact of Acute Kidney Injury With Temporary Dialysis on the Risk of FractureJournal of Bone and Mineral Research, 2013
- Bone involvement in aldosteronismJournal of Bone and Mineral Research, 2012
- Fracture Risk in Men With Congestive Heart FailureJACC, 2008
- Estimation of propensity scores using generalized additive modelsStatistics in Medicine, 2008
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsJACC, 2006
- Diuretics and Bone Loss in Rats With AldosteronismJACC, 2005
- Hyperparathyroidism and the Calcium Paradox of AldosteronismCirculation, 2005
- Colocalization of Glucocorticoid and Mineralocorticoid Receptors in Human BoneJournal of Bone and Mineral Research, 2001